HEALTH

Shareholders File Suit Against Bristol-Myers: Several lawsuits were filed against Bristol-Myers Squibb Co., charging the drug giant’s executives with misleading the public about the strength of its earnings. However, the company has said it did not make any specific projections about its results. Bristol-Myers stock plunged nearly 10% this week after the company downplayed industry estimates of the company’s sales and earnings for the second quarter and the full year. The company’s stock, which settled at $73.75 a share on Monday, closed Wednesday at $66.375, down 50 cents on the NYSE.